Optimal cumulative dose of cisplatin for concurrent chemoradiotherapy among patients with non-metastatic nasopharyngeal carcinoma: A multicenter analysis in Thailand

by Nuttapong Ngamphaiboon, Arunee Dechaphunkul, Jiraporn Setakornnukul, Tanadech Dechaphunkul, Rungarun Jiratrachu, Bhoom Suktitipat, Chuleeporn Jiarpinitnun, Poompis Pattaranutaporn, Pongwut Danchaivijitr
Published 2020

Benefits of prophylactic percutaneous gastrostomy in patients with nasopharyngeal cancer receiving concurrent chemoradiotherapy: A multicenter analysis

by Tanadech Dechaphunkul, Nuttapong Ngamphaiboon, Pongwut Danchaivijitr, Rungarun Jiratrachu, Sarayut Lucien Geater, Poompis Pattaranutaporn, Chuleeporn Jiarpinitnun, Jiraporn Setakornnukul, Bhoom Suktitipat, Arunee Dechaphunkul
Published 2022

Real-world evidence of cisplatin versus carboplatin in patients with locally advanced nasopharyngeal carcinoma receiving concurrent chemoradiotherapy: A multicenter analysis

by Arunee Dechaphunkul, Pongwut Danchaivijitr, Rungarun Jiratrachu, Tanadech Dechaphunkul, Chatsuda Sookthon, Chuleeporn Jiarpinitnun, Chatchanok Paoin, Jiraporn Setakornnukul, Bhoom Suktitipat, Poompis Pattaranutaporn, Nuttapong Ngamphaiboon
Published 2022

Osimertinib versus Standard of Care EGFR TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC: FLAURA Asian Subset

by Byoung Chul Cho, Busayamas Chewaskulyong, Ki Hyeong Lee, Arunee Dechaphunkul, Virote Sriuranpong, Fumio Imamura, Naoyuki Nogami, Takayasu Kurata, Isamu Okamoto, Caicun Zhou, Ying Cheng, Eun Kyung Cho, Pei Jye Voon, Jong Seok Lee, Helen Mann, Matilde Saggese, Thanyanan Reungwetwattana, Suresh S. Ramalingam, Yuichiro Ohe
Published 2018